Skip to main content
  • Book
  • © 2009

Adenosine Receptors in Health and Disease

Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 193)

Buy it now

Buying options

eBook USD 389.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 499.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (19 chapters)

  1. Front Matter

    Pages i-xiii
  2. A1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers

    • William F. Kiesman, Elfatih Elzein, Jeff Zablocki
    Pages 25-58
  3. Recent Developments in Adenosine A2A Receptor Ligands

    • Gloria Cristalli, Christa E. Müller, Rosaria Volpini
    Pages 59-98
  4. Recent Developments in A2B Adenosine Receptor Ligands

    • Rao V. Kalla, Jeff Zablocki, Mojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi
    Pages 99-122
  5. Medicinal Chemistry of the A3 Adenosine Receptor: Agonists, Antagonists, and Receptor Engineering

    • Kenneth A. Jacobson, Athena M. Klutz, Dilip K. Tosh, Andrei A. Ivanov, Delia Preti, Pier Giovanni Baraldi
    Pages 123-159
  6. Adenosine Receptors and the Heart: Role in Regulation of Coronary Blood Flow and Cardiac Electrophysiology

    • S. Jamal Mustafa, R. Ray Morrison, Bunyen Teng, Amir Pelleg
    Pages 161-188
  7. Adenosine Receptors and Reperfusion Injury of the Heart

    • John P. Headrick, Robert D. Lasley
    Pages 189-214
  8. Adenosine Receptors and Inflammation

    • Michael R. Blackburn, Constance O. Vance, Eva Morschl, Constance N. Wilson
    Pages 215-269
  9. A1 Adenosine Receptor: Role in Diabetes and Obesity

    • Arvinder K. Dhalla, Jeffrey W. Chisholm, Gerald M. Reaven, Luiz Belardinelli
    Pages 271-295
  10. A3 Adenosine Receptor: Pharmacology and Role in Disease

    • P.A. Borea, S. Gessi, S. Bar-Yehuda, P. Fishman
    Pages 297-327
  11. Adenosine Receptors and Asthma

    • Constance N. Wilson, Ahmed Nadeem, Domenico Spina, Rachel Brown, Clive P. Page, S. Jamal Mustafa
    Pages 329-362
  12. Adenosine Receptors, Cystic Fibrosis, and Airway Hydration

    • Gulnur Com, J.P. Clancy
    Pages 363-381
  13. Adenosine Receptors in Wound Healing, Fibrosis and Angiogenesis

    • Igor Feoktistov, Italo Biaggioni, Bruce N. Cronstein
    Pages 383-397
  14. Adenosine Receptors and Cancer

    • P. Fishman, S. Bar-Yehuda, M. Synowitz, J.D. Powell, K.N. Klotz, S. Gessi et al.
    Pages 399-441
  15. Adenosine Receptors and the Kidney

    • Volker Vallon, Hartmut Osswald
    Pages 443-470
  16. Adenosine Receptors and the Central Nervous System

    • Ana M. Sebastião, Joaquim A. Ribeiro
    Pages 471-534
  17. Adenosine Receptors and Neurological Disease: Neuroprotection and Neurodegeneration

    • Trevor W. Stone, Stefania Ceruti, Mariapia P. Abbracchio
    Pages 535-587
  18. Adenosine A2A Receptors and Parkinson’s Disease

    • Micaela Morelli, Anna R. Carta, Peter Jenner
    Pages 589-615
  19. Adenosine Receptor Ligands and PET Imaging of the CNS

    • Andreas Bauer, Kiichi Ishiwata
    Pages 617-642

About this book

Since their discovery approximately 25 years ago, adenosine receptors have now emerged as important novel molecular targets in disease and drug discovery. These proteins play important roles in the entire spectrum of disease from inflammation to immune suppression. Because of their expression on a number of different cell types and in a number of different organ systems they play important roles in specific diseases, including asthma, rheumatoid arthritis, Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, heart disease, stroke, cancer, sepsis, and obesity. As a result of intense investigations into understanding the molecular structures and pharmacology of these proteins, new molecules have been synthesized that have high specificity for these proteins and are now entering clinical trials. These molecules will define the next new classes of drugs for a number of diseases with unmet medical needs.

Editors and Affiliations

  • Endacea, Inc.,, Research Triangle Park, U.S.A.

    Constance N. Wilson

  • Health Sciences Center, West Virginia University, Morgantown, U.S.A.

    S. Jamal Mustafa

Bibliographic Information

Buy it now

Buying options

eBook USD 389.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 499.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access